If there's ever been an a earnings announcement when earnings themselves aren't important, it's Yahoo's fourth quarter.» Read More
Bears may have prevailed on Tuesday, but Jim Cramer wouldn't count out the bulls. Not by a long shot.
It's very risky to hold leveraged and inverse exchange-traded funds (ETFs) in the medium- and long-term.
If you’re not trading in underwear and socks, Cramer thinks you’re missing out.
Some of the names on the move ahead of the open.
Check out which companies are making headlines after the bell Tuesday: Analog Device, Intuit & more.
After a batch of new earnings reports, the overall trend remains the same: disappointing.
No matter how challenged the market may appear, there are always stocks that Cramer thinks are worth owning.
WWE lost about half its market value as its new deal with NBCUniversal failed to convince investors that it was capable of winning more subscribers.
While everyone is waiting for Alibaba to announce pricing terms, rival JD.com is set to go public this week.
Tepid yields on safe debt is driving traders to junk bonds and low-rated debt, and the push has fueled a number of mergers and acquisitions.
Sometimes you can learn as much about a merger from who isn't bidding as you can from who is.
Stocks advance as Putin orders troops pull back from Ukraine and lack of any negative headlines.
If the US economy improves as forecast, the Federal Reserve's current taper pace may be too slow, a Fed president said.
The big correction could come when the Fed ends its latest bond purchases, market analyst Peter Boockvar says.
The "green" corporate bond market will double in size this year, according to Standard & Poor's ratings services.
You can always find rotten performers in the mutual fund marketplace, but it's rare when you find one that has destroyed vast amount of wealth over a long period of time. USA Today reports.
The "Fast Money" traders share their final trades of the day.
Sometimes Jim Cramer finds stock ideas in the most interesting and unexpected places.
Activist investor William Ackman told Allergan's board that the CEO has a 'disabling' conflict of interest because a takeover means losing his job.
Former Fed chair Ben Bernanke made it clear to wealthy investors that super-low rates were going to be the norm.
Get the best of CNBC in your inbox